ChromoTek
Key Facts
| Invested since | 2010 |
| Based in | Bavaria |
About the company
ChromoTek products set new benchmarks for cellular research. ChromoTek develops and markets Chromobody®-based live cell assays for drug screening and target validation. Other products include immunological and bioimaging reagents such as the GFP-Trap® for the rapid pull-down of GFP fusion proteins and GFP/ RFP Booster to amplify the fluorescent signal of GFP or RFP fusion proteins. ChromoTek’s fluorescence based protein-protein interaction assay, called Fluorescence-2-Hybrid (F2H), is available as screening service for commercial customers and as off the shelf kit for academic research. More than 4,500 customers from all over the world trust in ChromoTek products.
Actin Chromobody visualizes cytoskeletal microfilaments in different cell types derived from human, mouse and hamster.
Lamin Chromobody highlights nuclear lamin in live cells and enables monitoring of cellular fate over hours for high-content analysis and drug discovery.
Do you want to
know more about this company?
ChromoTek in the news
Zum Artikel
Successful exit for High-Tech Gründerfonds and Bayern Kapital –Proteintech acquires ChromoTek
More startups from Life Sciences
Coramaze Technologies develops an innovative, highly differentiated, transcatheter tricuspid valve repair system, called TriPair. Headquartered in Germany with an R&D hub in Israel, we promote health equity by offering a …
Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA …
O11 biomedical, a visionary medical technology start-up that emerged as part of BioTex at RWTH Aachen University/ University Hospital Aachen 2022, aims to improve survival rates and quality of life …
CustomSurg, founded in 2021, is a Spin-Off from ETH Zurich and Harvard University. The company is developing software-as-a-medical-device (SaMD) solutions for the optimal selection and placement of orthopaedic implants in …
ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T cells that …
Smarterials Technology GmbH is a young MedTech company with high competence in the fields of inorganic chemistry, surface functionalization and process technology. The company was founded by two material scientists …
ADVANOVA was founded in January 2012 by Dr. Frank Hemer, a doctor and computer scientist, and Bastian Bleisinger, a computer scientist. The company’s head office is in Erlangen at the …
The core competency of AQ Implants GmbH is the endoprosthetic reconstruction of severe and complex defects and anomalies. With the development of innovative implant systems AQ Implants GmbH provides surgeons …
WMT developes small molecules for cancer indications by targeting the Warburg Metabolism. The Warburg Metabolism was first described 100 years ago by Otto Heinrich Warburg and the therapeutic approach is …
Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for …
RIMASYS offers prefractures specimen for educational purposes in the field of orthopedic surgery. The innovative MedTech company is setting new standards in surgical education and implant development through innovative education …
